Home » Active Pharmaceutical Ingredients (API)

Definition of Active Pharmaceutical Ingredient

 

 

An active pharmeceutical ingredient (API) or bulk active is the ingredient in a pharmaceutical drug that is biologically active. A natural product may have many active ingredientsor constituents.

In contrast with the active ingredients, the inactive ingredients are usually called excipients in pharmaceutical contexts. The main excipient that serves as a medium for conveying the active ingredient is usually called the vehicle. Petrolatum and mineral oil are common vehicles.

Therapeutic category of APIs

 

Anti alzheimer

Anti anginal

Anti anxiety,

Anti arrhytmic,

Anti cancer,

Anti coagulant,

Anti convulsant,

Anti depressant,

Anti diabetic,

Anti epileptic,

Anti fungal,

Anti hyperlipidemic,

Anti hypertensive,

Anti infective,

Anti inflammatory,

Anti migrant, Anti neoplastic, Anti osteoporosis, Anti parkinson, Anti platelet, Anti psychotic, Anti rheumatic, Anti spasmodic, Anti ulcerant, Antibiotic, Atrial fibrillation, Benign prostatic hyperplasia, Chronic heart failure, Chronic hepatitis c infection, Chronic myelogenous leukemia, CNS stimulant, Cystic fibrosis, Cytostatic agent, Diuretic, Erectile dysfunction,

Fibrosis, Gastroenterology, Idiopathic pulmonary fibrosis, Immunology, Inhibitor of braf serine  threonine  kinase, Iron chelating agents, Macrolides, Multiple sclerosis, Muscarinic receptor antagonist, Overactive bladder, Proton pump inhibitor, Pulmonary arterial hypertension, Src-Abl kinase inhibitor, Thrombine receptor, Tyrosine kinase inhibitor, Vitamin

Therapeutic category of APIs

 

Anti alzheimer

Anti anginal

Anti anxiety, Anti arrhytmic, Anti cancer, Anti coagulant, Anti convulsant, Anti depressant, Anti diabetic, Anti epileptic, Anti fungal, Anti hyperlipidemic, Anti hypertensive, Anti infective, Anti inflammatory, Anti migrant, Anti neoplastic, Anti osteoporosis, Anti parkinson, Anti platelet, Anti psychotic, Anti rheumatic, Anti spasmodic, Anti ulcerant, Antibiotic, Atrial fibrillation, Benign prostatic hyperplasia, Chronic heart failure, Chronic hepatitis c infection, Chronic myelogenous leukemia, CNS stimulant, Cystic fibrosis, Cytostatic agent, Diuretic, Erectile dysfunction,

Fibrosis, Gastroenterology, Idiopathic pulmonary fibrosis, Immunology, Inhibitor of braf serine  threonine  kinase, Iron chelating agents, Macrolides, Multiple sclerosis, Muscarinic receptor antagonist, Overactive bladder, Proton pump inhibitor, Pulmonary arterial hypertension, Src-Abl kinase inhibitor, Thrombine receptor, Tyrosine kinase inhibitor, Vitamin